Analysis of the NUDT15 gene and metabolites of azathioprine in Japanese patients with inflammatory bowel disease

• Published in: BMC gastroenterology 2023-07, Vol.23 (1), p.239-239, Article 239
• Main Authors: Suzuki, Shizuka, Uchiyama, Kan, Motoi, Yutaro, Yoshii, Yuuki, Inoue, Yukari, Kubota, Takahiro, Odahara, Shunichi, Ohtaki, Yuichiro, Takami, Shinichiro, Ito, Zensho, Sato, Nobuhiro, Ohkusa, Toshifumi, Koido, Shigeo, Saruta, Masayuki
• Format: Article
• Language: English
• Subjects: Alopecia; Analysis; Azathioprine; Azathioprine - adverse effects; Azathioprine - therapeutic use; Baldness; Blood; Bone marrow; Care and treatment; Chi-square test; Chromatography; Diagnosis; Dosage and administration; East Asian People; Enzymes; Gastroenterology; Gene polymorphism; Genes; Genetic aspects; Genetic polymorphisms; Hair loss; Humans; IBD; Inflammatory bowel disease; Inflammatory bowel diseases; Inflammatory Bowel Diseases - drug therapy; Inflammatory Bowel Diseases - genetics; Intestine; ITPA; Leukopenia; Leukopenia - chemically induced; Leukopenia - genetics; Mercaptopurine - adverse effects; Metabolites; Neutropenia; NUDT15; Patients; Polymorphism; Pyrophosphatase; Pyrophosphatases - genetics; Thioguanine; Toxicity
• ISSN: 1471-230X; 1471-230X
• DOI: 10.1186/s12876-023-02881-6

Thiopurines continue to play an important role in the treatment of inflammatory bowel disease (IBD). It is well known that thiopurines can cause several adverse reactions. Especially, hematopoietic toxicity may lead to severe agranulocytosis. In a previous prospective study, we investigated the relationship between inosine triphosphate pyrophosphatase (ITPA) c.94c > a polymorphism, 6-thioguanine nucleotide (6-TGN) concentration and toxicity. To clarify the cause of thiopurine toxicity, we analysed nucleoside disphosphate-linked moiety X-type motif 15 (NUDT15) gene polymorphisms, i.e., R139C, V18I, and V19_V19insGV, and measured 6-mercaptopurines and 6-methylmercaptopurines (6-MMP) using the archived blood samples collected from 49 IBD patients for our previous study. The ITPA c.94c > a polymorphism was detected in 19 patients (38.7%, all heterozygous). The R139C polymorphism was found in 10 patients (20.4%, 1 homozygous, 9 heterozygous), V18_V19insGV in 7 patients (14.3%, all heterozygous), and V18I in 2 patients (4.08%, all heterozygous). Although R139C was more strongly associated with leukopenia than c.94c > a, there were no significant correlations with 6-TGN and 6-MMP levels, as for c.94c > a. The leukopenia incidence rates for each gene polymorphism were 0% in those with all wild-type genes, 21.4% for c.94c > a only, 42.9% for NUDT15 polymorphism (s) only, and 80.0% for both polymorphisms. All cases of leukopenia were associated with ITPA c.94c > a and/or polymorphism of NUDT15 and the risk of developing leukopenia was synergistically increased by ITPA and NUDT15 gene polymorphism. However, there was no association between the level of azathioprine metabolites and these polymorphisms.